NCT06820190 Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion
| NCT ID | NCT06820190 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Multiple Mid-Transverse Process to Pleura |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-02-12 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-02-12 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the analgesic efficacy of multiple mid-transverse process to pleura (MTP) block and PCA in idiopathic scoliosis patients undergoing posterior spinal fusion surgery.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-II. * Idiopathic scoliosis patients undergoing posterior spinal fusion surgery. Exclusion Criteria: * Patients with pre-existing infection at block site. * Known allergy to study drugs. * Coagulation disorder. * History of psychiatric illness. * Pre-existing neurological deficits. * Patient with morbid obesity (body mass index \>40 kg/m2). * Presence of any pre-operative pain or history of chronic pain. * History of regular analgesic.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06820190 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Mid-Transverse Process to Pleura. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06820190 currently recruiting?
Yes, NCT06820190 is actively recruiting participants. Contact the research team at mselsharkawy@med.tanta.edu.eg for enrollment information.
Where is the NCT06820190 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT06820190 clinical trial?
NCT06820190 is sponsored by Tanta University. The trial plans to enroll 40 participants.